The Latest: Wisconsin Supreme Court strikes mask mandate

→ The World's First "$20 Trillion Drug?" (From Behind the Markets) (Ad)

This July 30, 2020, image taken from video by the Wisconsin Department of Health Services shows Wisconsin Gov. Tony Evers in Madison, Wis. The Wisconsin Supreme Court on Wednesday, March 31, 2021, struck down Gov. Evers' statewide mask mandate, ruling that the Democrat exceeded his authority by issuing the order. The 4-3 ruling from the conservative-controlled court is the latest legal blow to attempts by Evers to control the coronavirus. (Wisconsin Department of Health Services via the AP, File)

MADISON, Wis. — The Wisconsin Supreme Court struck down Gov. Tony Evers’ statewide mask mandate, ruling the Democrat exceeded his authority by issuing the order.

The 4-3 ruling from the conservative-controlled court is the latest legal blow to attempts by Evers to control the coronavirus. It comes after Republicans in the Legislature voted to repeal the mask mandate in February, only to see Evers quickly re-issue it.

The court last May struck down Evers’ “safer at home” order, saying that his health secretary didn’t have the authority for such an order. Evers’ attempts to limit capacity in bars, restaurants and other indoor places were also blocked by a state appeals court in October.

In the latest case, the court ruled that any public health emergency issued by Evers is valid for just 60 days and can’t be extended without legislative approval.

Evers had argued that he can issue multiple health emergencies because of the changing nature of the ongoing pandemic. The mask order first took effect in August and Evers extended it four times since then, most recently on Feb. 4.

___

THE VIRUS OUTBREAK:

— Pfizer says vaccine is safe in kids as young as age 12

— After three pandemic lockdowns, London tourism braces for slow recovery

— White House virus briefings have turned wonky, aiming to deliver facts and restore trust

— China’s loans impose unusual terms that hurt poor countries' ability to renegotiate debts after pandemic, researchers say

— Follow AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak

___

SEATTLE — A legal-aid group in Washington state has sued the state Department of Corrections, demanding that state prison inmates immediately receive COVID-19 vaccines.


The Seattle Times reported that Columbia Legal Services filed the class-action lawsuit on Tuesday seeking an order that would also ban direct contact with inmates by employees and contractors who refuse to be inoculated.

The lawsuit claims the state’s refusal to promptly vaccinate about 15,000 inmates violates the U.S. Constitution’s ban on cruel and unusual punishment. Agency spokesperson Jacque Coe said the department will continue to follow the state published vaccine phase schedule, which is based on age, underlying conditions and other factors.

___

CAIRO — The U.N. says Yemen has received first patch of coronavirus vaccines from the United Nations-backed COVAX initiative.

The 360,000 doses-shipment of the AstraZeneca vaccine has landed in the port city of Aden on Wednesday, in coordination with the World Health Organization and UNICEF, the two U.N. agencies said in a statement.

The doses have come amid a “dramatic influx” of critically ill COVID-19 patients in Yemen as a second wave of the pandemic overwhelms the country’s depleted medical facilities, according to the Medecins Sans Frontieres.

The shipment, produced by the Serum Institute in India, is the first patch of 1.9 million doses that Yemen will initially receive throughout 2021, it said.

Yemen has reported more than 3,800 infectious cases and 810 confirmed deaths.

___

BEIJING — Chinese health officials are pushing to expand the search for the origins of the coronavirus beyond China, one day after the release of a closely watched World Health Organization report on the issue.

They also are rejecting criticism that China didn’t give the international experts on the WHO team access to enough data when they visited the city of Wuhan earlier this year. The search for the origins of the virus has become a diplomatic feud. The U.S. and other Western nations have repeatedly raised questions about delays, transparency and data access, while China has promoted theories that suggest the virus may have come from elsewhere.

Liang Wannian, the head of the Chinese team that worked with the WHO group of experts, says the experts agreed that the place where the first case was identified is not necessarily where the virus emerged.

“Based on this scientific consensus, we should have a broader viewpoint in terms of sourcing,” he said.

Experts agree the virus could have come from elsewhere, with neighboring countries in Southeast Asia a prime possibility.

The WHO report concluded that the virus was most likely carried by a bat, which infected another animal that infected a human. Researchers haven’t been able to trace the bat or the intermediate animal yet, but suspicion has fallen on bat habitats in southwest China or nearby Southeast Asia.

___

GENEVA — The U.N. health agency says coronavirus cases globally rose for a fifth straight week, with counts in Africa and the Americas now ticking up after holding mostly steady for weeks.

Deaths climbed in every region except Africa. The World Health Organization says the number of new deaths rose 5 percent to more than 64,000 over the last week — a second straight weekly increase after falling or staying nearly flat for weeks.

Europe and the Americas still account for about four-fifths of all cases and deaths. The U.S. leads the world with 30.3 million coronavirus cases and nearly 551,000 deaths.

___

BRUSSELS — The European Union said member states will have received 107 million doses of COVID-19 vaccines by the end of this week.

The 27-nation bloc, which has secured more than 2 billion doses through contracts with various manufactures, initially expected far more shots in the first quarter. But delays in the deliveries and production issues with Anglo-Swedish company AstraZeneca have slowed down the rollout of vaccines in the region.

EU commission spokeswoman Dana Spinant says AstraZeneca is expected to have delivered about 29.7 million of doses, close to its revised target of 30 million, but far from the 120 million doses initially expected by the EU.

Despite the delays in deliveries, the EU’s executive Commission is sticking to its target to vaccinate 70% of the EU adult population by the end of the summer.

___

NEW YORK — Pfizer says its COVID-19 vaccine is safe and strongly protective in kids as young as 12.

The announcement Wednesday marks a step toward possibly beginning shots in this age group before the next school year.

Most COVID-19 vaccines being rolled out worldwide are for adults, who are at higher risk from the coronavirus. Pfizer’s vaccine is authorized for ages 16 and older. But vaccinating children of all ages will be critical to stopping the pandemic.

In a study of 2,260 U.S. volunteers ages 12 to 15, preliminary data showed there were no cases of COVID-19 among fully vaccinated adolescents compared to 18 among those given dummy shots.

Pfizer and its German partner BioNTech in the coming weeks plan to ask the U.S. Food and Drug Administration and European regulators to allow emergency use of the shots starting at age 12. Results are expected soon from a U.S. study of Moderna’s vaccine in 12- to 17-year-olds.

Children represent about 13% of COVID-19 cases documented in the U.S.

___

GENEVA — A top official with the World Health Organization says there’s “very little evidence” to suggest that three highly transmissible variants of the coronavirus cause more severe COVID-19 disease.

Dr. Kate O’Brien, director of WHO’s department of immunization, vaccines and biologicals, also says generally, the performance of vaccines against “the more severe end of the spectrum of disease” is stronger than against either infection or mild disease.

Dr. Alejandro Cravioto, head of a WHO panel of immunization experts, saus two Chinese vaccines from Sinovac and Sinopharm, which the U.N. health agency is assessing, have so far demonstrated “levels of efficacy that would be compatible with the requirements of WHO.”

He says those levels would be at least 50-percent effective and “preferably close to or above 70 percent.”

Craviato noted many national regulators have already approved the two vaccines for use, even without an emergency use listing that the Chinese manufacturers are seeking from WHO. Such a listing would allow them to be included in the U.N.-backed global vaccine rollout program known as COVAX.

A WHO decision on any emergency use listing for the two Chinese vaccines could come at the earliest next month, the agency says.

___

COLOMBO, Sri Lanka — Sri Lanka received 600,000 doses of the Sinopharm vaccine from China as a donation on Wednesday.

Sri Lankan authorities said the supplied doses will go first to Chinese citizens in Sri Lanka, where thousands of people from China are working.

Sri Lankan President Gotabaya Rajapaksa accepted the vaccine from Chinese Ambassador Qi Zhenhong at the airport after the doses were flown in on Wednesday.

Sri Lankan officials have said the vaccine will be given to Sri Lankans only after the island nation receives clearance from the World Health Organization.

Sinopharm is the third vaccine to be approved in Sri Lanka and the second the country has obtained in it’s fight against COVID-19.

Sri Lanka has so far used Oxford-AstraZeneca shots to vaccinate more than 903,000 people. The government also has arranged to buy 7 million doses of the Russian-developed vaccine Sputnik V.

___

BRUSSELS — Belgium has an extra unexpected hurdle to overcome in its fight against the coronavirus: a bout of gorgeous weather.

Temperatures in Belgium reached 24.5 degrees Celsius (76 F) on Tuesday, bringing thousands of people to coastal beaches and parks amid a worrying surge of COVID-19 cases.

The warm weather is expected to continue until Friday and the start of the Easter weekend. Good news for the 11.5 million Belgians craving sun after a gloomy winter, but a real worry for the government struggling to deal with a third wave of infections.

In response to the number of passengers on its trains, Belgium’s national rail company, SNCB, was forced to activate a “stop-and-go” system to prevent travelers from boarding in several train stations packed to the rafters.

Under the COVID-19 restrictions imposed in Belgium, residents are banned from traveling abroad but can move freely across the country. Many did not resist the appeal of a grand day out to the North Sea beaches, especially after the government decided last week to shut down schools for an extra week before the Easter school break in a bid to slow infections.

___

BUDAPEST — A surge in COVID-19 deaths in Hungary showed no sign of abating Wednesday as daily new cases hit a record 302. Hungary continues to have the highest weekly death rate per 1 million inhabitants in the world.

The Central European country is in its fourth week of a new round of lockdown measures aimed at reducing infections, hospitalizations and deaths, even as an ambitious vaccination program has given Hungary the highest vaccination rate in the European Union. The number of vaccinated people broke the 2 million mark on Tuesday, more than 20% of the population, and the foreign minister, Peter Szijjarto, announced Wednesday that a quarter million doses of Russia’s Sputnik V vaccine had arrived overnight in the capital, Budapest.

But mass vaccinations have been unable to turn around pandemic indicators, and Hungary’s hospitals are under unprecedented strain. As a proportion of the population, more COVID-19 patients are being treated in hospitals in Hungary than in any other EU country except Bulgaria.

On Wednesday, 28 news outlets signed an open letter to the government demanding more transparency concerning the pandemic, writing, “The lack of information has serious consequences.” The outlets asked for journalists to be allowed into hospitals to report on COVID-19 wards, and for medical staff, who are prohibited by ministerial decree from speaking to the media, to be permitted to give interviews.

___

PARIS — French President Emmanuel Macron has scheduled a televised address to the nation on Wednesday night, a possible harbinger of tighter restrictions to combat surging coronavirus hospitalizations.

Previous nationwide lockdowns in March and October of 2020 were announced by Macron in televised speeches. His office said Wednesday that he will address the nation at 8 p.m., without saying what he will announce.

Ahead of his weekly coronavirus strategy meeting Wednesday with ministers and aides, Macron was under intensifying pressure to close schools and further restrict people’s movements to ease the pressure on hospitals.

French hospital ICUs had to make room for another 569 new patients on Tuesday, pushing the nationwide total beyond 5,000 for the first time in 11 months.

___

TOKYO — Japan is calling for further investigation into the origins of COVID-19, saying the WHO report released this week was based on work that faced delays and lacked access to essential virus samples.

“In order to prevent future pandemics, it is indispensable to carry out prompt, independent and experts-led investigations that are free of surveillance,” Chief Cabinet Secretary Katsunobu Kato told reporters. “We are concerned that the latest investigation faced delays and the lack of access to virus samples.”

The World Health Organization’s report was released Tuesday after experts traveled to Wuhan, China, the city where illnesses from the coronavirus were first detected in late 2019.

China has touted its cooperation with WHO and warned that attempts to politicize the matter would cost lives. The U.S. and other countries say the WHO report lacked crucial information, access and transparency and further study was warranted.

Kato called for additional investigation and analysis and said Japan will encourage WHO to consider additional investigation inside China.

“We will further cooperate with other countries in carrying out additional studies that are still necessary,” Kato said.

The report said the virus most likely came from bats and spread to an unidentified mammal before being transmitted to people. It called a laboratory leak an unlikely route of transmission that didn’t warrant further study.

___

BEIJING — At least nine people have tested positive for COVID-19 in a Chinese city on the border with Myanmar, health officials said Wednesday.

Five are Chinese citizens are four are Myanmar nationals, the Yunnan Province Health Commission said in a report posted online. Three of the infected people did not have any COVID symptoms.

The city of Ruili, with a population of about 210,000 people, said all residents would be tested for COVID-19 and would have to home quarantine for one week. The residential compound where the infections were found has been locked down.

The city also ordered a crackdown on people who cross the border illegally, anyone who shelters them and those who organize such border crossings. It wasn’t immediately clear how the outbreak started.

China has largely eradicated the spread of the coronavirus and takes strict measures whenever a new cluster emerges.

___

→ The World's First "$20 Trillion Drug?" (From Behind the Markets) (Ad)

Should you invest $1,000 in Pfizer right now?

Before you consider Pfizer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.

While Pfizer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Pfizer (PFE)
4.9774 of 5 stars
$25.26-3.8%6.65%70.17Hold$36.33
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

7 Stocks to Help You Build Off January’s Gains

7 Stocks to Help You Build Off January’s Gains

It's frequently said that as January goes, so goes the market. If that's the case, it's time for investors to put money to work in the stock market.

Search Headlines: